GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (NAS:EKSO) » Definitions » Cyclically Adjusted PB Ratio

Ekso Bionics Holdings (Ekso Bionics Holdings) Cyclically Adjusted PB Ratio : 0.35 (As of Jun. 08, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ekso Bionics Holdings Cyclically Adjusted PB Ratio?

As of today (2024-06-08), Ekso Bionics Holdings's current share price is $1.10. Ekso Bionics Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.17. Ekso Bionics Holdings's Cyclically Adjusted PB Ratio for today is 0.35.

The historical rank and industry rank for Ekso Bionics Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

EKSO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.35   Med: 3.14   Max: 10.11
Current: 0.35

During the past years, Ekso Bionics Holdings's highest Cyclically Adjusted PB Ratio was 10.11. The lowest was 0.35. And the median was 3.14.

EKSO's Cyclically Adjusted PB Ratio is ranked better than
90.53% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs EKSO: 0.35

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ekso Bionics Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was $0.776. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.17 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ekso Bionics Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Ekso Bionics Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Cyclically Adjusted PB Ratio Chart

Ekso Bionics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.61 4.20

Ekso Bionics Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 2.64 1.28 4.20 0.43

Competitive Comparison of Ekso Bionics Holdings's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ekso Bionics Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Cyclically Adjusted PB Ratio falls into.



Ekso Bionics Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ekso Bionics Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.10/3.17
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ekso Bionics Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Ekso Bionics Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.776/131.7762*131.7762
=0.776

Current CPI (Mar. 2024) = 131.7762.

Ekso Bionics Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201406 -18.694 100.560 -24.497
201409 -6.106 100.428 -8.012
201412 18.181 99.070 24.183
201503 15.169 99.621 20.065
201506 11.057 100.684 14.472
201509 7.319 100.392 9.607
201512 6.785 99.792 8.960
201603 5.010 100.470 6.571
201606 1.103 101.688 1.429
201609 4.452 101.861 5.759
201612 3.453 101.863 4.467
201703 -0.731 102.862 -0.936
201706 0.731 103.349 0.932
201709 7.429 104.136 9.401
201712 5.353 104.011 6.782
201803 3.688 105.290 4.616
201806 1.880 106.317 2.330
201809 1.338 106.507 1.655
201812 0.650 105.998 0.808
201903 1.007 107.251 1.237
201906 1.082 108.070 1.319
201909 1.285 108.329 1.563
201912 1.173 108.420 1.426
202003 0.895 108.902 1.083
202006 -0.004 108.767 -0.005
202009 1.010 109.815 1.212
202012 0.531 109.897 0.637
202103 3.238 111.754 3.818
202106 3.168 114.631 3.642
202109 3.084 115.734 3.511
202112 2.932 117.630 3.285
202203 2.607 121.301 2.832
202206 2.439 125.017 2.571
202209 2.180 125.227 2.294
202212 1.927 125.222 2.028
202303 1.595 127.348 1.650
202306 1.290 128.729 1.321
202309 1.072 129.860 1.088
202312 0.849 129.419 0.864
202403 0.776 131.776 0.776

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ekso Bionics Holdings  (NAS:EKSO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ekso Bionics Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ekso Bionics Holdings (Ekso Bionics Holdings) Business Description

Traded in Other Exchanges
Address
101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
Executives
Jerome Wong officer: Interim CFO C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Scott G. Davis officer: President & COO C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Steven Sherman director
Jason C Jones officer: VP of Product Development EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
John Glenn officer: Chief Financial Officer 7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
Lathan Corinna director 140 KENDRICK STREET, NEEDHAM MA 02494
William R Shaw officer: See Remarks 1414 HARBOUR WAY SOUTH, SUITE 1201, C/O EKSO BIONICS HOLDINGS, INC., RICHMOND CA 94804
Rhonda A. Wallen director C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Mary Ann Cloyd director 184 LIBERTY CORNER ROAD, SUITE 302, WARREN NJ 07059
Combest Development (hong Kong) Ltd 10 percent owner ROOM 2210, CC WU BUILDING 302, HENNESSY ROAD, WAN CHAI, HONG KONG K3 999077
Jack Peurach director, officer: Chief Executive Officer 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Thomas A Schreck director 10240 BUBB RD, CUPERTINO CA 95014
Puissance Capital Management Lp 10 percent owner 950 THIRD AVENUE, 25TH FLOOR, NEW YORK NY 10022
Christian Babini officer: VP of Sales, Americas C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1, RICHMOND CA 94804
Puissance Cross-border Opportunities Ii Llc 10 percent owner C/O PUISSANCE CAPITAL FUND (GP) LLC, 950 THIRD AVENUE, NEW YORK NY 10022